ID: ALA2315298

Max Phase: Preclinical

Molecular Formula: C11H12ClFN2S2

Molecular Weight: 290.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(C)SSc1nc2cc(F)c(Cl)cc2[nH]1

Standard InChI:  InChI=1S/C11H12ClFN2S2/c1-3-6(2)16-17-11-14-9-4-7(12)8(13)5-10(9)15-11/h4-6H,3H2,1-2H3,(H,14,15)

Standard InChI Key:  ICFAURXPWJBIOV-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.82Molecular Weight (Monoisotopic): 290.0114AlogP: 4.89#Rotatable Bonds: 4
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.68CX Basic pKa: 3.75CX LogP: 4.92CX LogD: 4.92
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.81Np Likeness Score: -1.46

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source